Skip to main content

MARSHALL WACE, LLP

Position in NKTR — Nektar Therapeutics

CIK 1318757 LONDON, X0

Position in NKTR

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$230,373
-$9,884,933 QoQ
Shares Held
3,300
-97.7% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#180
of 239 holders
Holding Since
Jun 2021
11 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in NKTR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MARSHALL WACE, LLP holds $3,014,740,742 across 267 Biotechnology names. NKTR ranks #240 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in NKTR

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $230,373 3,300
2026-03-31 $10,115,306 140,588
2025-12-31 $1,015,692 24,023
2025-06-30 $366,928 14,200
2024-03-31 $1,368,250 1,471,237
2023-12-31 $1,336,294 2,386,241
2023-09-30 $1,761,730 2,936,218
2023-03-31 $37,730 53,900
2022-09-30 $99,660 31,144
2021-12-31 $495,046 36,643
2021-06-30 $1,522,967 88,751